Profile of antiphospholipid antibodies and complement system in COVID-19 patients of different severity
COVID-19, a severe acute respiratory syndrome caused by SARS-CoV-2, may predispose to thrombotic events, especially when combined with antiphospholipid antibodies (aPL). However, there are limited data on prevalence and antigenic specificity of aPL in COVID-19. Complement activation is assumed to pl...
Saved in:
| Main Authors: | N. V. Dolgushina, I. V. Menzhinskaya, O. S. Beznoshchenko, S. M. Mullabayeva, E. A. Gorodnova, L. V. Krechetova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2022-04-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/2465 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe hemolysis flare of refractory autoimmune hemolytic anemia with positive complement component C3d responsive to Iptacopan with cyclophosphamide and prednisone: a case report
by: Yawen Zhang, et al.
Published: (2025-12-01) -
Catastrophic antiphospholipid COVID-19 syndrome
by: Yu. S. Polushin, et al.
Published: (2021-03-01) -
Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
by: Z S Alekberova, et al.
Published: (2004-08-01) -
Infection-Triggered Antiphospholipid Syndrome: A Critical Overview
by: Smiyan S, et al.
Published: (2025-08-01) -
Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method
by: T. M. Reshetnyak, et al.
Published: (2025-04-01)